SolasCure
1 known investors
SolasCure is developing mechanism-driven therapeutics to address biological barriers in chronic wound healing, with its lead candidate Aurase Wound Gel completing Phase II clinical trials. The company serves clinicians and healthcare systems seeking clinically validated approaches to improve outcomes for patients with non-healing or slowly healing wounds.
Founders & leadership
LH
Lee HarleinChief Executive Officer
DB
Dr. Bela KeletyChief Technology Officer
Board
AW
Andy WeymannChairman
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BApr 2023Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does SolasCure do?
- SolasCure is developing mechanism-driven therapeutics to address biological barriers in chronic wound healing, with its lead candidate Aurase Wound Gel completing Phase II clinical trials. The company serves clinicians and healthcare systems seeking clinically validated approaches to improve outcomes for patients with non-healing or slowly healing wounds.
- Who are SolasCure's investors?
- SolasCure's investors include Seneca Partners.